Gabriela Mercado et al. [66] suppressed the PERK pathway with the PERK inhibitor GSK2606414, to attenuate endoplasmic reticulum stress, restore dopamine levels and synaptic protein expression, and consequently alleviate neurodegeneration in Parkinson’s disease. This evidence concerns the gene EIF2AK3 and Parkinson disease.